Cargando…
The great challenge of managing recipients of hematopoietic stem cell transplantation combined with COVID-19
Autores principales: | Lu, Xuan, Tang, Liang V., Wang, Hua-Fang, You, Yong, Wang, Ya-Dan, Hu, Yu, Shi, Wei, Xia, Ling-Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446604/ https://www.ncbi.nlm.nih.gov/pubmed/32843727 http://dx.doi.org/10.1038/s41409-020-01035-6 |
Ejemplares similares
-
Immune response to vaccination against SARS-CoV-2 in hematopoietic stem cell transplantation and CAR T-cell therapy recipients
por: Wu, Xi, et al.
Publicado: (2022) -
Antibody responses to SARS-CoV2 vaccination in allogeneic hematopoietic stem cell transplant recipients
por: Mamez, Anne-Claire, et al.
Publicado: (2021) -
The Essentials of Drug Interactions in Hematopoietic Stem Cell Transplantation
por: Gatwood, Katie S., et al.
Publicado: (2019) -
Viral Dynamics of SARS-CoV-2 in Critically Ill Allogeneic Hematopoietic Stem Cell Transplant Recipients and Immunocompetent Patients with COVID-19
por: Roedl, Kevin, et al.
Publicado: (2021) -
Efficacy and influencing factors of allogeneic hematopoietic stem cell transplantation in treatment of 71 children with leukemia
por: Zhang, Bing-Lei, et al.
Publicado: (2019)